Loading lessons…
Loading lessons…
Curated lessons across 8 learning paths — from first concepts to trial summaries and practical protocols. Pick your level, follow the curriculum, and build real understanding.
Where are you starting?
Choose a learning path below or search the library. Progress saves in your browser.
Prefer timeline chaos? Peptide X Quiz · Literacy certify
Pick a track — progress rings update as you complete lessons.
10 lessons
12mACE-031 is a discontinued myostatin-trapping drug sold online as a muscle builder. Its human trials were real, and so was the reason they stopped: a bleeding and blood-vessel signal traced to the one ligand the drug was never meant to catch. When an anti-doping laboratory tested fourteen products sold under the name, none of them contained ACE-031 at all.
9mTracking gear that syncs with Apple Health, recovery tools, sleep upgrades and four books worth wrapping. No prices that go stale overnight, just the picks and a link to check today's price.
11mFollistatin 344 is sold online as a muscle-building peptide. It is not a peptide: at 344 amino acids it is a protein. No published human trial has tested the injected product, the only follistatin-based drug to reach randomized trials grew muscle without improving function, and lab testing of black-market vials found most of them were not what the label said.
13mWe hunted down the gear that gets weight, sleep, heart rate and blood pressure into Apple Health automatically, plus the syringes and travel cases people actually restock in deal week. Bookmark it; we update it as deals drop.
9mLilly has sued 11 retatrutide sellers, FDA has sent warning letters, and Australia's regulator found a 'retatrutide' vial full of semaglutide. Here's the timeline and what it means if you're considering retatrutide.
7mPositive TRIUMPH-2 and TRIUMPH-3 results did not produce a 2026 filing. Lilly says the remaining work is in the CMC and manufacturing package.
8mGHK-Cu is not a magic skin fix. It is a copper peptide with a real research trail behind collagen support, tissue remodeling, and wound healing.
9mPeptides are not only treatment candidates anymore. New constrained ligands may help doctors see the tumor microenvironment more clearly, which changes how researchers think about diagnostics, targeting, and drug design.
8mMost people who take NAD+ daily wonder whether they should cycle it. The answer isn't black and white — it depends on your dose, delivery method, and goals. Here's what the research and community experience actually suggest.
12mRetatrutide is Lilly's investigational GIP/GLP-1/glucagon triple agonist. This hub covers what it is, what the trials actually reported about dosing and weight loss, how vial math works, where approval stands, and links to every retatrutide guide on PeptIQ.io.
Also available at /blog for legacy links.